A patient may be a candidate for GLP-1 weight loss if they have obesity, overweight with weight-related health concerns, insulin resistance, prediabetes, type 2 diabetes risk, high blood pressure, high cholesterol, fatty liver concerns, sleep apnea risk, or repeated difficulty losing and maintaining weight with lifestyle changes alone
Also, inform your doctor about all other medicines, and herbs that you take and your complete medical history
A brief, warm flushing sensation or head rush immediately after a CJC-1295 Ipamorelin injection is a completely normal and harmless physiological response indicating the peptide is binding to your pituitary receptors
At 2 to 3 mg daily The initiation phase produces the fewest side effects